[Tardive dyskinesia].
Neuroleptic drug treatment can produce tardive dyskinesia of which the incidence, risk factors, clinical characteristics and problems of differential diagnosis are described. Possible therapeutic approaches are then considered in the light of the hypothesis that the condition may derive from a physiopathological hypersensitivity of the dopamine receptors.
Sabbatini
F
F
Gentile
S
S
De Mattei
M
M
Pinessi
L
L
Rainero
I
I
D014150:Antipsychotic Agents / Q000009:adverse effects*; D002819:Chorea / Q000175:diagnosis; D003937:Diagnosis, Differential; D004409:Dyskinesia, Drug-Induced / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D004421:Dystonia / Q000175:diagnosis; D006801:Humans; D007558:Italy; D010300:Parkinson Disease / Q000175:diagnosis; D011954:Receptors, Dopamine / Q000187:drug effects; D012306:Risk; D013565:Sympatholytics / Q000009:adverse effects; D013981:Tic Disorders / Q000175:diagnosis
D014150:Antipsychotic Agents; D011954:Receptors, Dopamine; D013565:Sympatholytics
La discinesia tardiva.